HYALGAN
Fidia S.p.a.
| Research |
OneLook
Acronym Finder
|
| Serial Number | 73585251 |
| Registration Number | 1420772 |
| Mark Drawing Code | 1000: Typeset: Word(s)/letter(s)/number(s) |
| Domestic Representative | GEORGE W. COOPER |
| Attorney Name | DANIEL R. COOPER |
| Law Office Assigned | 550 |
Timeline
| 1986-02-28 | Application Filed |
| 1986-09-23 | Published for Opposition |
| 1986-12-16 | Trademark Registered |
| 2016-09-16 | Location: GENERIC WEB UPDATE |
| 2016-09-16 | Status: Live/Registered |
| 2016-12-16 | Renewal Date |
| 2018-07-07 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  FIDIA S.P.A. |
| Address | VIA PONTE DELLA FABBRICA 3/A ABANO TERME IT |
| Legal Entity Type | Joint Stock Company |
| Legal Entity State | IT |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 018 |
| Type Code | Type |
|---|---|
| GS0051 | PHARMACEUTICAL PREPARATIONS FOR TREATMENT OF BONE JOINT DISORDERS |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NON-FINAL ACTION MAILED | 1986-05-20 | 1 CNRT F:First Action |
| EXAMINERS AMENDMENT MAILED | 1986-05-29 | 2 CNEA O:Outgoing Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 1986-07-23 | 3 CNSA O:Outgoing Correspondence |
| NOTICE OF PUBLICATION | 1986-08-24 | 4 NPUB O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 1986-09-23 | 5 PUBO A:Allowance for Publication |
| REGISTERED-PRINCIPAL REGISTER | 1986-12-16 | 6 R.PR A:Allowance for Publication |
| REGISTERED - SEC. 8 (6-YR) FILED | 1992-12-14 | 7 8.AF I:Incoming Correspondence |
| REGISTERED - SEC. 8 (6-YR) ACCEPTED | 1993-04-14 | 8 8.OK O:Outgoing Correspondence |
| CASE FILE IN TICRS | 2006-09-26 | 9 CFIT O:Outgoing Correspondence |
| TEAS SECTION 8 & 9 RECEIVED | 2006-10-18 | 10 E89R I:Incoming Correspondence |
| REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED | 2006-10-18 | 11 89AF I:Incoming Correspondence |
| ASSIGNED TO PARALEGAL | 2006-12-19 | 12 PLGL A:Allowance for Publication |
| REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | 2007-01-02 | 13 89AG O:Outgoing Correspondence |
| REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | 2007-01-02 | 14 RNL1 Q: |
| UNDELIVERABLE MAIL - NO ACTION TAKEN | 2007-01-18 | 15 UNDN O:Outgoing Correspondence |
| TEAS SECTION 8 & 9 RECEIVED | 2016-06-24 | 16 E89R I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2016-09-16 | 17 APRE A:Allowance for Publication |
| REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | 2016-09-16 | 18 89AG O:Outgoing Correspondence |
| REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS) | 2016-09-16 | 19 RNL2 Q: |
| NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | 2016-09-16 | 20 NA89 E:E-Mail |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 HYALGAN 79202959 5388830 Live/Registered |
Fidia Farmaceutici S.p.A. 2016-07-19 |
 HYALGAN 73585251 1420772 Live/Registered |
FIDIA S.P.A. 1986-02-28 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 